Table 1.
Baseline evaluation.
Parameter | DHA group (n = 30) | Control group (n = 30) | p-value |
---|---|---|---|
Gender; n (%) | |||
Male | 11(36.7) | 10(33.3) | 0.787** |
Female | 19(63.3) | 20(66.7) | |
Gestational age (days); mean ± SD | 31.37 ± 1.5 | 31.40 ± 1.61 | 0.934* |
Age of admission (days); mean ± SD | 1.06 ± 0.36 | 1.27 ± 0.5 | 0.07* |
Anthropometric measures | |||
Baseline weight (g); mean ± SD | 1306.33 ± 152.94 | 1346.67 ± 123.13 | 0.265* |
Baseline length (cm); mean ± SD | 40.33 ± 1.97 | 39.27 ± 1.26 | 0.016* |
Baseline OFC (cm); mean ± SD | 28.30 ± 2 | 28.07 ± 0.98 | 0.570* |
Natal history | |||
Mode of delivery; n (%) | |||
LSCS | 18(60) | 20(66.7) | 0.592** |
VD | 12(40) | 10(33.3) | |
Maternal risk factors; n (%) | |||
Absent | 11(36.7) | 8(26.7) | 0.405** |
Present | 19(63.3) | 22(73.3) | |
Need for resuscitation; n (%) | |||
No | 9(30) | 10(33.3) | 0.781** |
Yes | 21(70) | 20(66.7) |
cm, centimeters; DHA, Docosahexaenoic acid; g, grams; LSCS, Lower segment caesarian section; OFC, Occipitofrontal circumference; SD, standard deviation; VD, Vaginal delivery.
Student t test; **Chi-Square Test.